This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P170043S013 |
Classification Name | None |
Applicant | |
PMA | P170043 |
Supplement | S013 |
Supplement Number | Date | Supplement Type |
---|---|---|
P170043 | Original Filing | |
S014 | 2022-05-31 | Normal 180 Day Track |
S013 | ||
S012 | 2022-02-04 | 30-day Notice |
S011 | ||
S010 | 2021-06-15 | Normal 180 Day Track |
S009 | 2021-03-25 | 135 Review Track For 30-day Notice |
S008 | 2020-12-07 | Normal 180 Day Track No User Fee |
S007 | 2020-03-03 | Normal 180 Day Track No User Fee |
S006 | 2020-03-03 | Normal 180 Day Track No User Fee |
S005 | ||
S004 | 2019-05-02 | 30-day Notice |
S003 | ||
S002 | 2018-07-23 | Normal 180 Day Track No User Fee |
S001 | 2018-07-23 | Normal 180 Day Track No User Fee |
Device ID | PMA | Supp |
---|---|---|
00853704002203 | P170043 | 000 |
00853704002319 | P170043 | 005 |